Menu Search
Equities

Aino Health AB (publ)

50V:DEU

Aino Health AB (publ)

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Aino Health AB (publ) grew revenues 20.15% from 19.91m to 23.92m while net income improved from a loss of 14.96m to a smaller loss of 10.66m.
Gross margin54.94%
Net profit margin-42.52%
Operating margin-38.87%
Return on assets-81.43%
Return on equity-331.13%
Return on investment-291.45%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Aino Health AB (publ) fell by 723.00k. Cash Flow from Financing totalled 5.57m or 23.30% of revenues. In addition the company used 6.26m for operations while cash from investing was breakeven.
Cash flow per share-0.044
Price/Cash flow per share--
Book value per share0.0147
Tangible book value per share-0.014
More ▼

Balance sheet in SEKView more

Aino Health AB (publ) has a Debt to Total Capital ratio of 5.26%, a lower figure than the previous year's 21.16%.
Current ratio0.5746
Quick ratio--
Total debt/total equity0.0555
Total debt/total capital0.0526
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.